...
首页> 外文期刊>Molecules >Unraveling the Roots of Selectivity of Peptide Affinity Reagents for Structurally Similar Ribosomal Inactivating Protein Derivatives
【24h】

Unraveling the Roots of Selectivity of Peptide Affinity Reagents for Structurally Similar Ribosomal Inactivating Protein Derivatives

机译:揭示结构相似的核糖体失活蛋白衍生物的肽亲和试剂的选择性根源。

获取原文

摘要

Peptide capture agents have become increasingly useful tools for a variety of sensing applications due to their ease of discovery, stability, and robustness. Despite the ability to rapidly discover candidates through biopanning bacterial display libraries and easily mature them to Protein Catalyzed Capture (PCC) agents with even higher affinity and selectivity, an ongoing challenge and critical selection criteria is that the peptide candidates and final reagent be selective enough to replace antibodies, the gold-standard across immunoassay platforms. Here, we have discovered peptide affinity reagents against abrax, a derivative of abrin with reduced toxicity. Using on-cell Fluorescence Activated Cell Sorting (FACS) assays, we show that the peptides are highly selective for abrax over RiVax, a similar derivative of ricin originally designed as a vaccine, with significant structural homology to abrax. We rank the newly discovered peptides for strongest affinity and analyze three observed consensus sequences with varying affinity and specificity. The strongest (Tier 1) consensus was FWDTWF, which is highly aromatic and hydrophobic. To better understand the observed selectivity, we use the XPairIt peptide–protein docking protocol to analyze binding location predictions of the individual Tier 1 peptides and consensus on abrax and RiVax. The binding location profiles on the two proteins are quite distinct, which we determine is due to differences in pocket size, pocket environment (including hydrophobicity and electronegativity), and steric hindrance. This study provides a model system to show that peptide capture candidates can be quite selective for a structurally similar protein system, even without further maturation, and offers an in silico method of analysis for understanding binding and down-selecting candidates. View Full-Text
机译:肽捕获剂由于易于发现,稳定性和鲁棒性,已成为用于各种传感应用的越来越有用的工具。尽管能够通过生物淘选细菌展示文库快速发现候选物,并使其易于以更高的亲和力和选择性成熟为蛋白质催化捕获(PCC)试剂,但正在进行的挑战和关键的选择标准是,候选肽和最终试剂必须具有足够的选择性,以至于取代抗体,这是整个免疫测定平台的黄金标准。在这里,我们发现了针对abrax(一种具有降低的毒性的abrin衍生物)的肽亲和试剂。使用细胞荧光激活细胞分选(FACS)分析,我们显示,相比RiVax(最初设计为疫苗的蓖麻毒蛋白的相似衍生物),该肽具有很高的结构同源性,对Rabax具有很高的选择性。我们对新发现的肽进行了最强的亲和力排名,并分析了三个观察到的具有不同亲和力和特异性的共有序列。最强烈的(第1层)共识是FWDTWF,它是高度芳香和疏水的。为了更好地了解所观察到的选择性,我们使用XPairIt肽-蛋白质对接方案来分析单个Tier 1肽的结合位置预测以及关于abrax和RiVax的共识。两种蛋白质上的结合位置曲线非常不同,我们确定这是由于口袋大小,口袋环境(包括疏水性和电负性)和位阻的差异所致。这项研究提供了一个模型系统,以显示肽捕获候选物即使在没有进一步成熟的情况下,对结构相似的蛋白质系统也具有相当高的选择性,并提供了一种计算机模拟分析方法,用于了解结合和向下选择候选物。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号